Constitutive RelB activation in v-Src-transformed fibroblasts: Requirement for IκB degradation

Journal of Cellular Biochemistry

Volumn 73, Issue 2, 1999, Pages 237-247

  Shain, Kenneth H ^a   Jove, Richard ^a,b   Olashaw, Nancy E ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

B; I B; NF B; Rel

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; FIBROBLAST CULTURE; IMMEDIATE EARLY GENE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; HYDROLYSIS; I-KAPPA B PROTEINS; MICE; MICE, INBRED BALB C; ONCOGENE PROTEIN PP60(V-SRC); PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0033135986     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990501)73:2<237::AID-JCB10>3.0.CO;2-H     Document Type: Article

References (85)

1. Alkalay I, Yaron A, Hatzubai A, Jung S, Avraham A, Gerlitz O, Pashut-Lavon I, Ben-Neriah Y. 1995. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol Cell Biol 15:1294-1301.
2. Baeuerle PA, Baltimore D. 1988. IκB: A specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
3. Baeuerle PA, Baltimore D. 1989. A p65 subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev 3:1689-1698.
4. Baeuerle PA, Henkel T. 1994. Function and activation of NF-κB in the immune system. Annual Rev Immunol 12:141-179.
5. 1 transition in mouse fibroblasts. Mol Cell Biol 11:4943-4951.
6. Beg AA, Baldwin AS. 1993. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 7:2064-2070.
7. Beg AA, Baltimore D. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
8. Beg AA, Finco TS, Nantermet PV, Baldwin AS. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBa: A mechanism for NF-κB activation. Mol Cell Biol 13:3301-3310.
9. Bours V, Villalobos J, Burd PR, Kelly K, Siebenlist U. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell cycle motifs. Nature 348:76-80.
10. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. 1995. Control of IκB-α proteolysis by site-specific signal-induced phosphorylation. Science 267:1485-1488.
11. Bull P, Morley KL, Hoekstra MF, Hunter T, Verma I. 1990. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transactivation domain. Mol Cell Biol 10:5473-5485.
12. Cao X, Guy GR, Tan YH. 1996. Activation and association of STAT3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603.
13. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597.
14. Chen ZJ, Parent L, Maniatis T. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitin-dependent protein kinase activity. Cell 84:853-862.
15. Cheng Q, Cant CA, Moll T, Hofer-Warbinek R, Wagner E, Birnstiel ML, Bach FH, de Martin R. 1994. NF-κB subunit-specific regulation of the IκBα promoter. J Biol Chem 269:13551-13557.
16. Cogswell PC, Scheinman RI, Baldwin AS. 1993. Promoter of the human NF-κB p50/p105 gene: Regulation by NF-κB subunits and c-Rel. J Immunol 150:2794-2804.
17. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-584.
18. DiDonato JA, Mercurio F, Karin M. 1995. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol Cell Biol 15:1302-1311.
19. Dignam JD, Lebowitz RM, Roeder RG. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nuc Acids Res 11:1475-1489.
20. Dobrzanski P, Ryseck R-P, Bravo R. 1994. Differential interactions of Rel-NF-κB complexes determine pools of constitutive and inducible NF-κB activity. EMBO J. 13:4608-4616.
21. Dobrzanski P, Ryseck RP, Bravo R. 1995. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10:1003-1007.
22. Duckett CS, Perkins ND, Leung K, Agranoff AB, Nabel GJ. 1995. Cytokine induction of nuclear factorκB in cycling and growth-arrested cells: Evidence for cell cycle-independent activation. J Biol Chem 270:18836-18840.
23. Eicher DM, Tan TH, Rice NR, O'Shea JJ, Kennedy ICS. 1994. Expression of v-Src in T cells correlates with nuclear expression of NF-κB. J Immunol 152:2710-2719.
24. Fan C-H, Maniatis T. 1991. Generation of the p50 sububit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354:395-398.
25. Ferreira V, Tarantino N, Körner M. 1998. Discrimination between RelA and RelB transcriptional regulation by a dominant negative mutant of IκBα. J Biol. Chem 273:592-599.
26. Finco TS, Beg AA, Baldwin AS. 1994. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 91:11884-11888.
27. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS. 1997. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J Biol Chem 272:24113-24116.
28. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U. 1992. The candidate oncoprotein BCL-3 is an antagonist of p50/NF-κB-mediated inhibition, Nature 359:339-341.
29. Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan GP, Baltimore D. 1990. Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal. Cell 62: 1019-1029.
30. Haskill S, Beg AA, Tompkins SM, Morris JS, Yuruchko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS. 1991. Characterization of an immediate-early gene induced in monocytes that encodes IκB-like activity. Cell 65:1281-1289.
31. Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C. 1992. The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc Natl Acad Sci USA 89:2489-2493.
32. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle P. 1993. Rapid proteolysis of IκB-α is necessary in the activation of transcription factor NF-κB. Nature 365:182-185.
33. Inoue J-I, Kerr LD, Kakizuka A, Verma IM. 1992a. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family. Cell 68:1109-1120.
34. Inoue J-I, Kerr LD, Rashid D, Davis N, Bose HR, Verma IM. 1992b. Direct association of pp40/IκBβ with Rel/NF-κB transcription factors: Role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci USA 89:4333-4337.
35. Johnson DR, Douglas I, Jahnke A, Ghosh S, Pober JS. 1996. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J Biol Chem 271:16317-16322.
36. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. 1994. Constitutive NF-κB activity in neurons. Mol Cell Biol 14:3981-3992.
37. + T lymphocytes. Science 256:1452-1456.
38. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, LeBail O, Urban M, Kourilsky P, Baeuerle PA. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
39. Kistler B, Rolink A, Marienfeld R, Neumann M, Wirth T. 1998. Induction of nuclear factor-κB during promary B cell differentiation. J Immunol 160:2308-2317.
40. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS, Huang E-S. 1993. Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 90:1107-1111.
41. LeBail O, Schmidt-Ullrich R, Israel A. 1993. Promoter analysis of the gene encoding the IκBα/MAD3 inhibitor of NF-κB: Positive regulation by members of the Rel/NF-κB family. EMBO J 12:5043-5049.
42. Lenardo MJ, Fan, CM, Maniatis T, Baltimore D. 1989. The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287-294.
43. Lernbacher T, Kistler B, Wirth T. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J 13:4060-4069.
44. Lernbacher T, Muller U, Wirth T. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770.
45. Li Z, Nabel GJ. 1997. A new member of of the IκB protein family, IκB∈, inhibits RelA (p65)-mediated NF-κB transcription. Mol Cell Biol 17:6184-6190.
46. Lin Y-C, Brown K, Siebenlist U. 1995. Activation of NF-κB requires rapid proteolysis of the inhbitor IκB-α: Signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Natl Acad Sci USA 92:552-556.
47. Liou H-C, Nolan GP, Ghosh S, Fujita T, Baltimore D. 1992. The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J 11:3003-3009.
48. Liou HC, Sha WC, Scott ML, Baltimore D. 1994. Sequential induction of NF-κB/Rel family proteins during B cell terminal differentiation. Mol Cell Biol 14:5349-5359.
49. Liu Z, Hau H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
50. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540-544.
51. McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard D. 1996. Inactivation of IκBβ by the tax protein of human T-cell leukemia virus type 1: A potential mechansim for constitutive induction of NF-κB. Mol Cell Biol 16:2083-2090.
52. Mellits KH, Hart RT, Goodbourn S. 1993. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res 21:5059-5066.
53. Mercurio F, DiDonato JA, Rosette C, Scheidereit C. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev 7:705-718.
54. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li JW, Young DB, Barbosa M, Mann M, Mamming A, Rao A. 1997. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
55. Miyamoto S, Chiao PJ, Verma IM. 1994. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B cell lines. Mol Cell Biol 14:3276-3282.
56. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge G. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629-3639.
57. Nolan GP, Fujita T, Bhatia K, Huppi C, Liou H-C, Scott M, Baltimore D. 1993. The bcl-3 proto-oncogene encodes a protein that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 13:3557-3566.
58. Ohno H, Takimoto G, McKeithan TW. 1990. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997.
59. Olashaw NE. 1996. Inducible activation of RelB in fibroblasts. J Biol Chem 271:30307-30310.
60. Olashaw NE, Kowalik TF, Huang H-S, Pledger WJ. 1992. Induction of NF-κB-like activity by platelet-derived growth factor in mouse fibroblasts. Mol Biol Cell 3:1131-1139.
61. Palombella V, Rando OJ, Goldberg AL, Maniatis T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
62. Qureshi SA, Alexandropoulos K, Rim M, Joseph CK, Bruder JT, Rapp UR, Foster DA. 1992. Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src. J Biol Chem 267:17635-17639.
63. Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr. 1998. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev 12:968-981.
64. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
65. Rice NR, MacKichan ML, Israel A. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253.
66. Ryseck R-P, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol Cell Biol 12:674-684.
67. Sartor CI, Dziubinski ML, Yu C-L, Jove R, Ethier ST. 1997. Role of epidermal growth factor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57:978-987.
68. Schmitz ML, Baeuerle PA. 1991. The p65 subunit is responsible for the strong transcription activation potential of NF-κB. EMBO J 10:3805-3817.
69. Sen R, Baltimore D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
70. Sen J, Venkataraman L, Shinkai Y, Pierce JW, Alt FW, Burakoff SJ, Sen R. 1995. Expression and induction of NF-κB-related proteins in thymocytes. J Immunol 154: 3213-3221.
71. Siebenlist U, Franzoso G, Brown K. 1994. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405-455.
72. Simeonidis S, Liang S, Chen G, Thanos D. 1997. Cloning and functional characterization of mouse IκB∈. Proc Natl Acad Sci USA 94:14372-14377
73. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh, S. 1995. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
74. Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in reponse to diverse stimuli. EMBO J 14:2876-2883.
75. Ueberla K, Lu YC, Chung E, Haseltine WA. 1993. The NF-κB promoter. J AIDS Res 6:227-230.
76. Van Antwerp DJ, Martin SJ, Kafri T, Green D, Verma IM. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
77. Wang C-Y, Mayo MW, Baldwin AS. 1996. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784-787.
78. Weih F, Carrasco D, Bravo R. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9:3289-3296.
79. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, Lira SA, Bravo R. 1995. Multiorgan inflammation and hematopoeitic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
80. Weih F, Lira SA, Bravo R. 1996. Overexpression of RelB in transgenic mice does not affect IκBα levels: Differential regulation of RelA and RelB by the inhibitor protein. Oncogene 12:445-449.
81. Whiteside ST, Epinat J-C, Rice NR, Israel A. 1997. I kappa B epsilon, a novel member of the IκB family, controls RelA and c-Rel NF-κB activity. EMBO J 16:1413-1426.
82. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. 1997. IκB kinase: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866-869.
83. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. 1995. Enhanced DNA binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science 269:61-63.
84. Yu CL, Prochownik EV, Imperiale MJ, Jove R. 1993. Attenuation of serum inducibility of immediate early genes by oncoproteins in tyrosine kinase signaling pathways. Mol Cell Biol 13:2011-2019.
85. Zabel U, Baeuerle PA. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61:255-265.